40
Participants
Start Date
April 28, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
TIL
On day 0, cells will be infused intravenously over 20 to 30 minutes (one to four days after the last dose of fludarabine)
Aldesleukin
IL-2 125,000 IU/kg/day IV (based on total body weight) beginning within 24 hours of cell infusion and continuing for up to 2 weeks
Cyclophosphamide
On day -7 and day -6: Cyclophosphamide 60 mg/kg/day X 2 days IV in 250 ml D5W over 1 hr.
Fludarabine
Days -5 to -1: Fludarabine 25 mg /m2/day IVPB daily over 30 minutes for 5 days
RECRUITING
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Tongji Hospital
OTHER